Around 670 people in England with epidermolysis bullosa will benefit from the treatment
The National Institute for Health and Care Excellence (NICE) has recommended Amryt Pharmaceuticals’ Filsuvez (birch bark extract) to treat skin wounds associated with dystrophic and junctional epidermolysis bullosa (EB).
Affecting around 500,000 people worldwide, EB is a general term for a group of rare inherited skin disorders that cause the skin to become very fragile, causing blisters, tears and the loss of skin segments…
